1422 companies · 1443 sector slots · 20 sectors · 27 below Rs1000cr and not scanned · long-term lens
Trend Spotlight
IOC has run without an independent-director quorum for over six months, suspending its Audit, NRC and CSR committees, while posting a Q1 FY27 standalone net loss of ₹2,662cr.
Since March 28, 2026, Indian Oil Corporation has lacked a quorum of independent directors (including the mandated woman independent director), forcing its Audit, Nomination & Remuneration and CSR committees into suspension; NSE and BSE have both issued SEBI LODR non-compliance notices, and a further independent director resigned Sept 18, 2026. Separately, IOC posted a Q1 FY27 standalone net loss of ₹2,662.37cr (vs a ₹5,688.60cr profit a year earlier) on LPG under-recovery and margin compression, even as revenue rose. Neither fact alone forces a call change, but a non-functional Audit Committee for half a year at one of the largest names in the universe is a governance gap a long-term holder should track rather than wave off as a one-day headline.
Positive overnight cues point to a gap-up open; the RBI's rate call Wednesday is the week's key event risk.
Wall Street closed at fresh records Monday (Nasdaq +1.05%, S&P 500 +0.66%) on AI-dealmaking strength and a softer US jobs print that eased Fed-hike worries, while Japan's Nikkei rallied roughly 5% to a record on Sanae Takaichi's LDP leadership win and a weaker yen (USD/JPY toward 150.44). GIFT Nifty points to a positive open after Nifty extended its gain for a third straight session Monday, closing above 25,000 (+0.74% to 25,077.65). The RBI's MPC, in session since Oct 5, delivers its decision Oct 7 at 10am IST; a Reuters poll of 61 economists split with 35 expecting a first hike since Feb 2023 (25bps to 5.50%), against elevated Brent crude (sources disagree on the exact Oct 5 level — $101.31/bbl per TradingEconomics vs $105.81/bbl per Fortune) and a rupee drifting toward 96.3+. September CPI isn't out until Oct 12, after the decision, so the Committee is acting on August's 4.82% print.
Good business, bad price today (Value 1/5) — PEG 1.19; P/E cheaper than 31% of sector peers (P/E 38.14); EV/EBITDA 32.8, B/M 0.127. Watch for a better entry.
Good business, bad price today (Value 2/5) — PEG 28.26; P/E cheaper than 81% of sector peers (P/E 28.26); EV/EBITDA 17.0, B/M 0.226. Watch for a better entry.
Good business, bad price today (Value 2/5) — PEG 0.49; P/E cheaper than 57% of sector peers (P/E 35.02); EV/EBITDA 27.0, B/M 0.107. Watch for a better entry.
Good business, bad price today (Value 1/5) — PEG 0.66; P/E cheaper than 20% of sector peers (P/E 57.59); EV/EBITDA 39.8, B/M 0.079. Watch for a better entry.
Good business, bad price today (Value 1/5) — PEG n/a; P/E cheaper than 9% of sector peers (P/E 40.07); EV/EBITDA 16.3, B/M 0.283. Watch for a better entry.
Source: NSE event calendar, filtered to the 1422 tracked names.
Market Overview
Index
Close
Points
Change
P/E
P/B
Nifty 50
22,555.75
▲ +133.80
▲ +0.60%
19.30
2.77
Nifty Next 50
69,213.75
▲ +232.40
▲ +0.34%
18.14
3.33
Nifty 500
21,971.60
▲ +113.85
▲ +0.52%
21.67
3.08
Nifty Bank
54,714.10
▲ +263.35
▲ +0.48%
12.97
1.65
NIFTY Midcap 100
59,123.65
▲ +391.65
▲ +0.67%
27.88
3.76
▲ 1245 advancing■ 28 unchanged▼ 1375 decliningof 2648 equities, vs the 2026-10-01 close
Cash market, ₹ crore
FII / FPI net
▼ -4,699.14
bought 15,675 · sold 20,374
DII net
▲ +5,181.62
bought 20,493 · sold 15,311
FII / FPI
DII
Source: NSE ind_close_all_20261005
(levels, index P/E and P/B) and the full-market bhavcopy (breadth).
Index P/E from NSE's official daily index file.
Since We Flagged
The desk's track record — every call it has published, scored over the
stretch it actually stood: from the close on the day it was made (restated for any
split or bonus) to the day the desk changed it, the name left coverage, or today.
Each is set against Nifty 500 over the same window. A BUY should beat it; an AVOID
should lag it.
3459 calls scored since Wed, 5 Aug 2026: 1338 standing, 1533 closed when the desk changed the call, 588 closed when the name left coverage (at its last published close). 2010 of them are the call a name was given on entering coverage, not one the desk changed to. 1326 more standing calls with history are not shown — this table is the 12 that have moved most against Nifty 500 since they were made. 79 calls published this session are not scored yet — no session to move in. 22 have no cached close at one end of their window and are not scored. 7 entry prices restated for a split or bonus inside the window (marked adj.).
Supreme Court sets Oct 12 hearing on hospital drug markups, floats a uniform 16% cap Healthcare & Hospitals
The Supreme Court bench of Justices Vikram Nath and Sandeep Mehta questioned the Centre on Sept 29 over why DPCO 2013's existing 16% retail-margin cap on medicines isn't enforced, citing a cancer drug priced at Rs 2,700 to retailer vs Rs 27,000 MRP, and raised concerns about hospitals requiring patients to buy only from in-house pharmacies. The matter returns Oct 12 with the Centre due to respond. No formal regulatory proposal has been notified yet, so this stays an open, unresolved risk thread for corporate-hospital pharmacy economics rather than a confirmed rule change.
Zen Technologies' order book still at ₹1,239cr; anti-drone tenders not yet floated Capital Goods
As of June 30, 2026, Zen Technologies' consolidated order book stood at ₹1,239cr — the same Q1-end figure already on record — with no progress yet toward the ~₹2,500cr FY27 target management has reaffirmed. The flagged ₹2,000cr+ anti-drone opportunity remains unconverted, with some anticipated tenders still not floated. New product launches (an AI anti-drone system, the Hyperstrike interceptor, the Zen Vrishab UGV) support the pipeline narrative but are not yet bookable orders.
CONCOR raises full-year volume guidance as the JNPA rail link ramps up Logistics & Transport
Container Corporation of India revised its full-year volume growth guidance upward to EXIM 15%, domestic 25% and overall 18%, helped by the dedicated freight corridor link to JNPA commissioned June 20, 2026; management expects a bigger road-to-rail shift from October onward as the monsoon eases. A routine government-nominee board rotation in March was the only governance item found, and no client-loss evidence turned up.
Ahead of Q2 FY27 results, Pricol withdrew specific numeric growth guidance, citing high uncertainty, and said input-cost pressure will likely be shared across the value chain rather than fully absorbed — management could only commit to growth 'higher than the market growth rate' while flagging a 'softening of earnings.' CRISIL still reaffirmed its AA-/Watch Developing rating Oct 1, and the company reiterated its P3L unit remains on track to double turnover in three years, partially offsetting the pullback.
Sun Pharma holds FY27 revenue guidance as specialty and innovative-medicines growth continues Pharmaceuticals
Management reaffirmed high-single-digit FY27 revenue growth guidance on the Q1 call despite acknowledging rising US generic pricing pressure. FY26 innovative-medicines revenue grew 16.8% to $1.42bn, and the US Innovative Medicines business has crossed $1bn with continued ex-US momentum; 122 ANDAs await USFDA approval. This cuts against the pending BUY->HOLD call-flip evidence, though the finding rests on a single earnings-call transcript and has not been independently corroborated.
Entry score is 40% cheap-vs-history + 25% quality trend + 15% technicals, renormalised over those three — the 20% news catalyst is not counted because no research was written for this session. It is not treated as neutral; it is absent. ≥62 accumulate · 45–61 watch · <45 avoid.
Source: data/verdicts.json × NSE sector index closes.
Stocks to Watch
Split evenly across large/mid/small/micro cap so this list isn't one
tier's picks — new calls first, then the highest long-term composites within each.
Micro-cap names are boxed and flagged Highly Volatile — worth
watching, not a call to buy — since their price swings run about twice every other
tier's. Each card shows the figures that selected it — open the desk for the full
six-lens panel.